SEC Filings for Pluristem Therapeutics Inc. (PSTI)

$ 4.46   0.01 (+0.22%) Volume: 37.3k 3:59 PM EST 21-Feb-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
10-QGeneral form for quarterly reports under Section 13 or 15(d)3702/06/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)3411/07/2019
10-KAnnual report pursuant to Section 13 or 15(d)13609/12/2019
8-KCurrent report pursuant to Section 13 or 15(d)308/12/2019
8-KCurrent report pursuant to Section 13 or 15(d)507/25/2019
8-KCurrent report pursuant to Section 13 or 15(d)707/02/2019
8-KCurrent report pursuant to Section 13 or 15(d)106/24/2019
8-KCurrent report pursuant to Section 13 or 15(d)106/13/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)1105/06/2019
DEF 14AOther definitive proxy statements104/25/2019
DEFA14AAdditional proxy soliciting materials - definitive104/26/2019
8-KCurrent report pursuant to Section 13 or 15(d)104/15/2019
PRE 14APreliminary proxy statement providing notification matters to be brought to a vote104/15/2019
4Statement of changes in beneficial ownership of securities104/08/2019
4Statement of changes in beneficial ownership of securities104/08/2019
<<
First
<
Prev
123456789101112131415